Here are four notes:
1. The transaction was valued at $90,207.
2. Mr. Phillips sold the shares at an average price of $23.10 per share.
3. He currently owns 11,557 Exactech shares.
4. On April 13, Robert W. Baird upgraded Exactech shares to an “outperform” rating.
More articles on devices:
4 trends in outpatient spine surgery from Amendia
InVivo Therapeutics adds Penn Medicine as INSPIRE study site: 4 points
DJO Global reports Q1 12.7% net sales growth, $38.3M net loss: 7 key notes
